GlaxoSmithKline Biologicals
The computed 12-month bankruptcy probability of GlaxoSmithKline Biologicals is 0.8% (low). The company has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 36 yrs |
| Board | 22 |
| Locations | 5 |
| Publications | 73 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 02-07-2025 | 2025-00232893 |
| 31-12-2023 | volledig | 29-07-2024 | 2024-00307097 |
| 31-12-2022 | volledig | 06-07-2023 | 2023-00227154 |
| 31-12-2021 | volledig | 20-07-2022 | 2022-20227409 |
| 31-12-2020 | volledig | 15-07-2021 | 2021-36800522 |
| 31-12-2019 | volledig | 30-07-2020 | 2020-37200383 |
| 31-12-2018 | volledig | 17-07-2019 | 2019-35400334 |
| 31-12-2017 | volledig | 02-07-2018 | 2018-28800086 |
| 31-12-2016 | volledig | 11-07-2017 | 2017-31200148 |
| 31-12-2015 | volledig | 26-07-2016 | 2016-35700420 |
-
Current28-07-2026 → present
-
Current02-04-2026 → present
2 events
- 28-07-2026 Mandate renewed· Director
- 02-04-2026 Appointed· Director
-
Current02-04-2026 → present
-
Current03-09-2025 → present
2 events
- 28-07-2026 Mandate renewed· Director
- 03-09-2025 Appointed· Director
-
Current03-09-2025 → present
-
Current25-06-2025 → present
2 events
- 03-09-2025 Appointed· Managing director
- 25-06-2025 Appointed· Director
Show 16 more sitting directors
-
Current05-08-2024 → present
3 events
- 28-07-2026 Mandate renewed· Director
- 25-06-2025 Mandate renewed· Director
- 05-08-2024 Mandate renewed· Director
-
Current03-07-2024 → present
2 events
- 30-07-2025 Appointed· Director
- 03-07-2024 Appointed· Director
-
Current18-09-2023 → present
-
Current28-06-2023 → present
-
Current28-06-2023 → present
4 events
- 28-07-2026 Mandate renewed· Director
- 25-06-2025 Mandate renewed· Director
- 05-08-2024 Mandate renewed· Director
- 28-06-2023 Mandate renewed· Director
-
Current28-06-2023 → present
4 events
- 28-07-2026 Mandate renewed· Director
- 25-06-2025 Mandate renewed· Director
- 05-08-2024 Mandate renewed· Director
- 28-06-2023 Mandate renewed· Director
-
Current28-06-2023 → present
4 events
- 28-07-2026 Mandate renewed· Director
- 25-06-2025 Mandate renewed· Director
- 05-08-2024 Mandate renewed· Director
- 28-06-2023 Mandate renewed· Director
-
Current28-06-2023 → present
4 events
- 28-07-2026 Mandate renewed· Director
- 25-06-2025 Mandate renewed· Director
- 05-08-2024 Mandate renewed· Director
- 28-06-2023 Mandate renewed· Director
-
Current10-01-2023 → present
-
Current10-01-2023 → present
-
Current10-01-2023 → present
-
Current23-02-2022 → present
3 events
- 30-07-2025 Appointed· Director
- 03-07-2024 Appointed· Director
- 23-02-2022 Appointed· Director
-
Current23-06-2021 → present
2 events
- 22-06-2022 Mandate renewed· Director
- 23-06-2021 Appointed· Director
-
Current26-06-2019 → present
4 events
- 22-06-2022 Mandate renewed· Director
- 30-07-2021 Mandate renewed· Director
- 24-06-2020 Mandate renewed· Director
- 26-06-2019 Appointed· Director
-
Current24-06-2015 → present
6 events
- 03-09-2025 Appointed· Managing director
- 10-01-2023 Appointed· Director
- 27-06-2018 Mandate renewed· Director
- 28-06-2017 Mandate renewed· Director
- 24-08-2016 Mandate renewed· Director
- 24-06-2015 Appointed· Director
-
Current23-06-2010 → present
18 events
- 23-02-2022 Appointed· Daily management delegate
- 30-07-2021 Mandate renewed· Director
- 24-06-2020 Mandate renewed· Director
- 18-11-2019 Appointed· Managing director
- 26-06-2019 Mandate renewed· Director
- 27-06-2018 Mandate renewed· Director
- 28-06-2017 Mandate renewed· Director
- 24-08-2016 Mandate renewed· Director
- 24-06-2015 Mandate renewed· Director
- 25-06-2014 Mandate renewed· Director
- 26-06-2013 Mandate renewed· Director
- 27-06-2012 Mandate renewed· Director
- 24-06-2011 Mandate renewed· Director
- 22-06-2011 Mandate renewed· Director
- 23-06-2010 Mandate renewed· Director
- 21-09-2009 Resigned· Director
- 24-06-2009 Mandate renewed· Director
- 29-09-2003 Mandate renewed· Director
Historic, not recently confirmed (17)
-
Not recently confirmedlast confirmed in an act from 2020
10 events
- 24-06-2020 Mandate renewed· Director
- 26-06-2019 Appointed· Director
- 28-06-2017 Mandate renewed· Director
- 24-08-2016 Mandate renewed· Director
- 24-06-2015 Mandate renewed· Director
- 25-06-2014 Mandate renewed· Director
- 26-06-2013 Mandate renewed· Director
- 27-06-2012 Mandate renewed· Director
- 24-06-2011 Mandate renewed· Director
- 22-06-2011 Mandate renewed· Director
-
Not recently confirmedlast confirmed in an act from 2020
12 events
- 24-06-2020 Mandate renewed· Director
- 26-06-2019 Mandate renewed· Director
- 27-06-2018 Mandate renewed· Director
- 28-06-2017 Mandate renewed· Director
- 24-08-2016 Mandate renewed· Director
- 24-06-2015 Mandate renewed· Director
- 25-06-2014 Mandate renewed· Director
- 26-06-2013 Mandate renewed· Director
- 27-06-2012 Mandate renewed· Director
- 24-06-2011 Mandate renewed· Director
- 22-06-2011 Mandate renewed· Director
- 23-06-2010 Appointed· Director
-
Not recently confirmedlast confirmed in an act from 2019
6 events
- 26-06-2019 Mandate renewed· Director
- 27-06-2018 Mandate renewed· Director
- 28-06-2017 Mandate renewed· Director
- 24-08-2016 Mandate renewed· Director
- 24-06-2015 Mandate renewed· Director
- 25-06-2014 Appointed· Director
-
Not recently confirmedlast confirmed in an act from 2018
13 events
- 27-06-2018 Mandate renewed· Director
- 28-06-2017 Mandate renewed· Director
- 24-08-2016 Mandate renewed· Director
- 24-06-2015 Mandate renewed· Director
- 25-06-2014 Mandate renewed· Director
- 26-06-2013 Mandate renewed· Director
- 27-06-2012 Mandate renewed· Director
- 24-06-2011 Mandate renewed· Director
- 22-06-2011 Mandate renewed· Director
- 23-06-2010 Mandate renewed· Director
- 21-09-2009 Resigned· Director
- 24-06-2009 Mandate renewed· Director
- 29-09-2003 Appointed· Director
-
Not recently confirmedlast confirmed in an act from 2018
2 events
- 27-06-2018 Mandate renewed· Director
- 20-07-2016 Appointed· Director
-
Not recently confirmedlast confirmed in an act from 2018
2 events
- 27-06-2018 Appointed· Director
- 28-06-2017 Appointed· Director
-
Not recently confirmedlast confirmed in an act from 2018
-
Not recently confirmedlast confirmed in an act from 2015
4 events
- 24-06-2015 Mandate renewed· Director
- 25-06-2014 Mandate renewed· Director
- 26-06-2013 Mandate renewed· Director
- 27-06-2012 Appointed· Director
-
Not recently confirmedlast confirmed in an act from 2014
2 events
- 25-06-2014 Mandate renewed· Director
- 26-06-2013 Mandate renewed· Director
-
Not recently confirmedlast confirmed in an act from 2014
-
Not recently confirmedlast confirmed in an act from 2014
7 events
- 25-06-2014 Mandate renewed· Director
- 26-06-2013 Mandate renewed· Director
- 27-06-2012 Mandate renewed· Director
- 24-06-2011 Mandate renewed· Director
- 22-06-2011 Mandate renewed· Director
- 23-06-2010 Mandate renewed· Director
- 24-06-2009 Appointed· Director
-
Not recently confirmedlast confirmed in an act from 2012
-
Not recently confirmedlast confirmed in an act from 2010
-
A. RappagliosiDélégué à la gestion journalière (bureau de bruxelles)State Gazette act 10021667 (10-02-2010)Not recently confirmedlast confirmed in an act from 2010
-
Géraldine JoulinDélégué à la gestion journalière (bureau de bruxelles)State Gazette act 10021667 (10-02-2010)Not recently confirmedlast confirmed in an act from 2010
-
Not recently confirmedlast confirmed in an act from 2003
-
Not recently confirmedlast confirmed in an act from 2003
Former directors (16)
-
Former28-06-2023 → 31-03-2026
4 events
- 31-03-2026 Resigned· Director
- 25-06-2025 Mandate renewed· Director
- 05-08-2024 Mandate renewed· Director
- 28-06-2023 Mandate renewed· Director
-
Former28-06-2023 → 03-09-2025
4 events
- 03-09-2025 Resigned· Director
- 25-06-2025 Mandate renewed· Director
- 05-08-2024 Mandate renewed· Director
- 28-06-2023 Mandate renewed· Director
-
Former22-04-2022 → 03-09-2025
7 events
- 03-09-2025 Resigned· Director
- 03-09-2025 Resigned· Managing director
- 30-07-2025 Appointed· Director
- 03-07-2024 Appointed· Director
- 22-06-2022 Mandate renewed· Director
- 07-05-2022 Appointed· Managing director
- 22-04-2022 Appointed· Director
-
Former23-02-2022 → 30-07-2025
4 events
- 30-07-2025 Resigned· Director
- 03-07-2024 Appointed· Director
- 23-02-2022 Appointed· Président du conseil de gouvernance
- 23-02-2022 Appointed· Director
-
Former27-06-2012 → 15-09-2023
12 events
- 15-09-2023 Resigned· Director
- 22-06-2022 Mandate renewed· Director
- 30-07-2021 Mandate renewed· Director
- 24-06-2020 Mandate renewed· Director
- 26-06-2019 Mandate renewed· Director
- 27-06-2018 Mandate renewed· Director
- 28-06-2017 Mandate renewed· Director
- 24-08-2016 Mandate renewed· Director
- 24-06-2015 Mandate renewed· Director
- 25-06-2014 Mandate renewed· Director
- 26-06-2013 Mandate renewed· Director
- 27-06-2012 Appointed· Director
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Deloitte Réviseurs d'EntreprisesCurrent Statutory auditor · represented by Gert Vanhees |
- | 28-06-2017 → present |
Show 1 earlier auditors
| Michel Lange Commissaire succeeded by Deloitte Réviseurs d'Entreprises in 2017 |
- | 21-09-2009 → 28-06-2017 |
| NACE primary | Vervaardiging van geneesmiddelen(21201) |
| Legal form | Public limited company(014) |
| Incorporation | 01-07-1990 |
| Status | Active |
| Postal code | 1330 |
Show 2 more network connections
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25112C0097/00P000 | Wallonia | 30.5 ha | 1 · 4,249 m² | 24.5 m · 7 fl. |
| 25091G0001/00B002 | Wallonia | 16.7 ha | 1 · 2,458 m² | - |
| 25112C0020/00N000 | Wallonia | 1.3 ha | 1 · 891 m² | 14.6 m · 4 fl. |
| 21805E0345/00C000 | Brussels | 716 m² | 1 · 716 m² | 32.8 m · 10 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Of the 74 Belgian State Gazette acts we know for this company, 71 have been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.
28-07-2026 General meeting · Officer resignation · Officer appointment · Officer reappointment
- Publication: 28/07/2026 · GlaxoSmithKline Biologicals SA
- Filing: 16/07/2026 · GlaxoSmithKline Biologicals SA
- General meeting: 24/06/2026 · GlaxoSmithKline Biologicals SA
- Officer resignation: role: administrateur, end_date: 2025-09-03 · E. Amory
- Officer resignation: role: administrateur, end_date: 2026-03-31 · J. Louahed
- Officer appointment: role: administrateur, start_date: 2025-09-03 · C. Noirhomme
- Officer appointment: role: administrateur, start_date: 2026-04-02 · D. Descamps
- Officer reappointment: role: administrateur · I. Rapilly
- Officer reappointment: role: administrateur · C. Noirhomme
- Officer reappointment: role: administrateur · D. Descamps
- Officer reappointment: role: administrateur · A. Van Goethem
- Officer reappointment: role: administrateur · R. Simard
- Officer reappointment: role: administrateur · B. Alsteens
- Officer reappointment: role: administrateur · E. Felix
- Officer reappointment: role: administrateur · P. Legraive
- Mandate compensation: gratuité · GlaxoSmithKline Biologicals SA
- Auditor appointment: role: commissaire, end_date: issue de l'assemblée générale ordinaire des actionnaires qui se prononcera sur les comptes clos au 31 décembre 2026 · Deloitte Réviseurs d'Entreprises
- Permanent representative · Koen Neijens
- Filing representative · Claude COPIN
- Auditor fees: year: 2025, amount: 1.590.880 EUR, conditions: hors TVA, débours divers et cotisation IRE · Deloitte Réviseurs d'Entreprises
- Auditor fees: year: 2026, amount: 1.750.000 EUR, conditions: hors TVA, débours divers et cotisation IRE · Deloitte Réviseurs d'Entreprises
Technical details
{
"facts": [
{
"date": "2026-07-28",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 28/07/2026",
"value": "28/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-16",
"type": "filing",
"quote": "TRIBUNAL DE L\u0027ENTREPRISE 16 JUIL. 2026 DU BRABANT WALLON",
"value": "16/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-06-24",
"type": "general_meeting",
"quote": "Extrait du Proc\u00E8s-Verbal de l\u0027Assembl\u00E9e G\u00E9n\u00E9rale Ordinaire tenue le 24 juin 2026",
"value": "24/06/2026",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "d\u00E9mission de M. E. Amory ... avec effet respectivement le 3 septembre 2025",
"value": {
"role": "administrateur",
"end_date": "2025-09-03"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "administrateur",
"end_date": "03/09/2025"
}
},
{
"type": "officer_resignation",
"quote": "d\u00E9mission de ... Mme J. Louahed ... avec effet ... le 31 mars 2026",
"value": {
"role": "administrateur",
"end_date": "2026-03-31"
},
"object": "e1",
"subject": "e3",
"_value_raw": {
"role": "administrateur",
"end_date": "31/03/2026"
}
},
{
"date": "2025-09-03",
"type": "officer_appointment",
"quote": "ratifie la cooptation de Mmes C. Noirhomme ... en qualit\u00E9 d\u0027administrateurs ... \u00E0 dater respectivement du 3 septembre 2025",
"value": {
"role": "administrateur",
"start_date": "2025-09-03"
},
"object": "e1",
"subject": "e4",
"_value_raw": {
"role": "administrateur",
"start_date": "03/09/2025"
}
},
{
"date": "2026-04-02",
"type": "officer_appointment",
"quote": "ratifie la cooptation de ... D. Descamps en qualit\u00E9 d\u0027administrateurs ... \u00E0 dater ... du 2 avril 2026",
"value": {
"role": "administrateur",
"start_date": "2026-04-02"
},
"object": "e1",
"subject": "e5",
"_value_raw": {
"role": "administrateur",
"start_date": "02/04/2026"
}
},
{
"type": "officer_reappointment",
"quote": "l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s ... Mmes I. Rapilly",
"value": {
"role": "administrateur"
},
"object": "e1",
"subject": "e6"
},
{
"type": "officer_reappointment",
"quote": "l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s ... C. Noirhomme",
"value": {
"role": "administrateur"
},
"object": "e1",
"subject": "e4"
},
{
"type": "officer_reappointment",
"quote": "l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s ... D. Descamps",
"value": {
"role": "administrateur"
},
"object": "e1",
"subject": "e5"
},
{
"type": "officer_reappointment",
"quote": "l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s ... A. Van Goethem",
"value": {
"role": "administrateur"
},
"object": "e1",
"subject": "e7"
},
{
"type": "officer_reappointment",
"quote": "l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s ... MM. R. Simard",
"value": {
"role": "administrateur"
},
"object": "e1",
"subject": "e8"
},
{
"type": "officer_reappointment",
"quote": "l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s ... B. Alsteens",
"value": {
"role": "administrateur"
},
"object": "e1",
"subject": "e9"
},
{
"type": "officer_reappointment",
"quote": "l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s ... E. F\u00E9lix",
"value": {
"role": "administrateur"
},
"object": "e1",
"subject": "e10"
},
{
"type": "officer_reappointment",
"quote": "l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s ... P. Legraive",
"value": {
"role": "administrateur"
},
"object": "e1",
"subject": "e11"
},
{
"type": "mandate_compensation",
"quote": "L\u0027assembl\u00E9e confirme \u00E0 l\u0027unanimit\u00E9 la gratuit\u00E9 des mandats d\u0027administrateur.",
"value": "gratuit\u00E9",
"object": null,
"subject": "e1"
},
{
"type": "auditor_appointment",
"quote": "Le mandat de commissaire de la soci\u00E9t\u00E9 civile sous forme de SCRL, Deloitte R\u00E9viseurs d\u0027Entreprises ... expire l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires qui se prononcera sur les comptes clos au 31 d\u00E9cembre 2026 et ne doit donc pas \u00EAtre renouvel\u00E9 cette ann\u00E9e.",
"value": {
"role": "commissaire",
"renewed": false,
"end_date": "issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires qui se prononcera sur les comptes clos au 31 d\u00E9cembre 2026"
},
"object": "e1",
"subject": "e12"
},
{
"type": "permanent_representative",
"quote": "repr\u00E9sent\u00E9e par Monsieur Koen Neijens",
"value": null,
"object": "e12",
"subject": "e13"
},
{
"type": "filing_representative",
"quote": "Claude COPIN, Mandataire",
"value": null,
"object": "e1",
"subject": "e14"
},
{
"type": "auditor_fees",
"quote": "Les honoraires du commissaire pour l\u0027audit des comptes 2025 sont de 1.590.880 EUR (hors TVA, d\u00E9bours divers et cotisation IRE).",
"value": {
"year": "2025",
"amount": "1.590.880 EUR",
"conditions": "hors TVA, d\u00E9bours divers et cotisation IRE"
},
"object": "e1",
"subject": "e12"
},
{
"type": "auditor_fees",
"quote": "Les honoraires pour l\u0027audit des comptes 2026 sont estim\u00E9s \u00E0 un montant maximum de 1.750.000 EUR (hors TVA, d\u00E9bours divers et cotisation IRE).",
"value": {
"max": true,
"year": "2026",
"amount": "1.750.000 EUR",
"conditions": "hors TVA, d\u00E9bours divers et cotisation IRE"
},
"object": "e1",
"subject": "e12"
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 3536,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0440.872.918",
"kind": "company",
"name": "GlaxoSmithKline Biologicals SA",
"attrs": {
"seat": "89 rue de l\u0027Institut - 1330 Rixensart",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"short_name": "GSK Biologicals"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "E. Amory",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "J. Louahed",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "C. Noirhomme",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "D. Descamps",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "I. Rapilly",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "A. Van Goethem",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "R. Simard",
"attrs": {}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "B. Alsteens",
"attrs": {}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "E. Felix",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "P. Legraive",
"attrs": {}
},
{
"id": "e12",
"kbo": null,
"kind": "org",
"name": "Deloitte R\u00E9viseurs d\u0027Entreprises",
"attrs": {
"seat": "Gateway Building, Luchthaven Nationaal 1J, 1930 Zaventem",
"legal_form": "Soci\u00E9t\u00E9 coop\u00E9rative \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e13",
"kbo": null,
"kind": "person",
"name": "Koen Neijens",
"attrs": {}
},
{
"id": "e14",
"kbo": null,
"kind": "person",
"name": "Claude COPIN",
"attrs": {}
}
]
}14-07-2026 Board meeting · Accounting effect · Power of attorney · Filing representative
- Publication: 14/07/2026 · GlaxoSmithKline Biologicals SA
- Filing: 03/07/2026 · GlaxoSmithKline Biologicals SA
- Board meeting: 11/05/2026 · GlaxoSmithKline Biologicals SA
- Accounting effect: 01/07/2026 · GlaxoSmithKline Biologicals SA
- Power of attorney: scope: gestion journalière du site de Wavre · Emmanuel Félix
- Power of attorney: scope: gestion journalière du site de Rixensart · Philippe Denoël
- Power of attorney: scope: gestion du bureau de Bruxelles situé - Clockwise Brussels (company name: Arts 44 SRL) Avenue des Arts 44, 1040 Bruxelles · Alberto Giummarra
- Filing representative · Claude Copin
Technical details
{
"facts": [
{
"date": "2026-07-14",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 14/07/2026 - Annexes du Moniteur belge",
"value": "14/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-03",
"type": "filing",
"quote": "03 JUIL. 2026",
"value": "03/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-05-11",
"type": "board_meeting",
"quote": "Extrait du Proc\u00E8s-Verbal de la r\u00E9union du Conseil d\u0027Administration tenue le 11 mai 2026",
"value": "11/05/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-01",
"type": "accounting_effect",
"quote": "applicables \u00E0 partir du 1er juillet 2026",
"value": "01/07/2026",
"object": null,
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "la gestion journali\u00E9re du site de Wavre est d\u00E9l\u00E9gu\u00E9e \u00E0 Mr Emmanuel F\u00E9lix",
"value": {
"scope": "gestion journali\u00E8re du site de Wavre"
},
"object": "e1",
"subject": "e2"
},
{
"type": "power_of_attorney",
"quote": "la gestion journali\u00E8re du site de Rixensart est d\u00E9l\u00E9gu\u00E9e \u00E0 Mr Philippe Deno\u00EBl",
"value": {
"scope": "gestion journali\u00E8re du site de Rixensart"
},
"object": "e1",
"subject": "e3"
},
{
"type": "power_of_attorney",
"quote": "Le conseil d\u0027administration d\u00E9l\u00E8gue la gestion du bureau de Bruxelles situ\u00E9 - Clockwise Brussels (company name: Arts 44 SRL) Avenue des Arts 44, 1040 Bruxelles, \u00E0 Mr Alberto Giummarra",
"value": {
"scope": "gestion du bureau de Bruxelles situ\u00E9 - Clockwise Brussels (company name: Arts 44 SRL) Avenue des Arts 44, 1040 Bruxelles"
},
"object": "e1",
"subject": "e4"
},
{
"type": "filing_representative",
"quote": "Claude Copin, Mandataire",
"value": null,
"object": "e1",
"subject": "e5"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 60831,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0440.872.918",
"kind": "company",
"name": "GlaxoSmithKline Biologicals SA",
"attrs": {
"seat": "89 rue de I\u0027Institut - 1330 Rixensart",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"short_name": "GSK Biologicals"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Emmanuel F\u00E9lix",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Philippe Deno\u00EBl",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Alberto Giummarra",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Claude Copin",
"attrs": {}
}
]
}08-06-2026 Officer resignation · Officer appointment · Permanent representative · Board meeting
- Filing: 2026-05-29 · GlaxoSmithKline Biologicals SA
- Publication: 2026-06-08 · GlaxoSmithKline Biologicals SA
- Officer resignation: role: administrateur et administrateur délégué, effective_date: 2026-03-31 · Jamila Louahed
- Officer appointment: role: administrateur, mandate_end: issue de l'assemblée générale amenée à se prononcer sur les comptes clos au 31 décembre 2025, compensation: gratuit, effective_date: 2026-04-02 · Dominique Descamps
- Permanent representative: role: gestion journalière du site de Rixensart, effective_date: 2026-04-02 · Philippe Denoel
- Board meeting: 2026-04-02 · GlaxoSmithKline Biologicals SA
- Power of attorney: role: Mandataire · Claude COPIN
- Act object: Nomination/démission d'un administrateur et d'un administrateur délégué
Technical details
{
"facts": [
{
"type": "filing",
"quote": "29 MAI 2026",
"value": "2026-05-29",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 08/06/2026",
"value": "2026-06-08",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "Le Conseil a pris acte de la d\u00E9mission de Mme Jamila Louahed de ses fonctions d\u0027administrateur et d\u0027administrateur d\u00E9l\u00E9gu\u00E9 de la Soci\u00E9t\u00E9 ainsi que de sa renonciation \u00E0 tous les pouvoirs qui lui ont \u00E9t\u00E9 conf\u00E8r\u00E9s, avec effet au 31mars 2026.",
"value": {
"role": "administrateur et administrateur d\u00E9l\u00E9gu\u00E9",
"effective_date": "2026-03-31"
},
"object": "e1",
"subject": "e2"
},
{
"type": "officer_appointment",
"quote": "Il a d\u00E9cid\u00E9 avec effet au 2 avril 2026 de : - Coopter Mme Dominique Descamps comme administrateur pour achever le mandat de Mme Louahed, sur base de l\u0027article 7: 88 du CSA. Le mandat de Mme Descamps prendra fin \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale amen\u00E9e \u00E0 se prononcer sur les comptes clos au 31 d\u00E9cembre 2025. Il rappelle, pour autant que de besoin, que le mandat est exerc\u00E9 \u00E0 titre gratuit.",
"value": {
"role": "administrateur",
"mandate_end": "issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale amen\u00E9e \u00E0 se prononcer sur les comptes clos au 31 d\u00E9cembre 2025",
"compensation": "gratuit",
"effective_date": "2026-04-02"
},
"object": "e1",
"subject": "e3"
},
{
"type": "permanent_representative",
"quote": "D\u00E9l\u00E9guer, la gestion journali\u00E8re du site de Rixensart \u00E0 M. Philippe Denoel, en vertu de l\u0027article 20 b) des statuts.",
"value": {
"role": "gestion journali\u00E8re du site de Rixensart",
"effective_date": "2026-04-02"
},
"object": "e1",
"subject": "e4"
},
{
"type": "board_meeting",
"quote": "Extrait du Proc\u00E8s-Verbal du Conseil d\u0027Administration du 2 avril 2026",
"value": "2026-04-02",
"object": null,
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "Claude COPIN Mandataire",
"value": {
"role": "Mandataire"
},
"object": "e1",
"subject": "e5"
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Nomination/d\u00E9mission d\u0027un administrateur et d\u0027un administrateur d\u00E9l\u00E9gu\u00E9",
"value": "Nomination/d\u00E9mission d\u0027un administrateur et d\u0027un administrateur d\u00E9l\u00E9gu\u00E9",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 1959,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0440.872.918",
"kind": "company",
"name": "GlaxoSmithKline Biologicals SA",
"attrs": {
"seat": "89 rue de l\u0027Institut - 1330 Rixensart",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"short_name": "GSK Biologicals"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Jamila Louahed",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Dominique Descamps",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Philippe Denoel",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Claude COPIN",
"attrs": {
"role": "Mandataire"
}
}
]
}05-11-2025 3 directors appointed, 2 resigning
- Christelle Noirhomme, Bestuurder
- Emmanuel Felix, Gedelegeerd bestuurder
- Jamila Louahed, Gedelegeerd bestuurder
- Emmanuel Amory, Bestuurder
- Emmanuel Amory, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel Amory",
"address": null,
"birth_date": null
},
"effective_date": "2025-09-03",
"evidence_quote": "M. Emmanuel Amory a remis au Conseil sa lettre de d\u00E9mission de ses fonctions d\u0027administrateur et d\u0027administrateur-d\u00E9l\u00E9gu\u00E9 de GlaxoSmithKline Biologicals SA, avec effet au 3 septembre 2025."
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel Amory",
"address": null,
"birth_date": null
},
"effective_date": "2025-09-03",
"evidence_quote": "M. Emmanuel Amory a remis au Conseil sa lettre de d\u00E9mission de ses fonctions d\u0027administrateur et d\u0027administrateur-d\u00E9l\u00E9gu\u00E9 de GlaxoSmithKline Biologicals SA, avec effet au 3 septembre 2025."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Christelle Noirhomme",
"address": null,
"birth_date": null
},
"effective_date": "2025-09-03",
"evidence_quote": "Il a d\u00E9cid\u00E9, avec effet au 3 septembre 2025, de: coopter Mme. Christelle Noirhomme, Head of Belgium Corporate Government Affairs, comme administrateur pour achever le mandat de M. Amory, sur base de l\u0027article 7: 88 du CSA."
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel Felix",
"address": null,
"birth_date": null
},
"effective_date": "2025-09-03",
"evidence_quote": "d\u00E9l\u00E9guer la gestion journali\u00E8re du site de Wavre \u00E0 M. Emmanuel Felix, administrateur, et celle des sites de Rixensart et Gembloux \u00E0 Mme Jamila Louahed, administrateur, en vertu de l\u0027article 20 b) des statuts. M. Felix et Mme Louahed porteront le titre d\u0027administrateur d\u00E9l\u00E9gu\u00E9."
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Jamila Louahed",
"address": null,
"birth_date": null
},
"effective_date": "2025-09-03",
"evidence_quote": "d\u00E9l\u00E9guer la gestion journali\u00E8re du site de Wavre \u00E0 M. Emmanuel Felix, administrateur, et celle des sites de Rixensart et Gembloux \u00E0 Mme Jamila Louahed, administrateur, en vertu de l\u0027article 20 b) des statuts. M. Felix et Mme Louahed porteront le titre d\u0027administrateur d\u00E9l\u00E9gu\u00E9."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}03-09-2025 1 director appointed, 7 reappointed
- Emmanuel Félix, Bestuurder
- I. Rapilly, Bestuurder
- A. Van Goethem, Bestuurder
- J. Louahed, Bestuurder
- R. Simard, Bestuurder
- E. Amory, Bestuurder
- B. Alsteens, Bestuurder
- P. Legraive, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "I. Rapilly",
"address": null,
"birth_date": null
},
"effective_date": "2025-06-25",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "A. Van Goethem",
"address": null,
"birth_date": null
},
"effective_date": "2025-06-25",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "J. Louahed",
"address": null,
"birth_date": null
},
"effective_date": "2025-06-25",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "R. Simard",
"address": null,
"birth_date": null
},
"effective_date": "2025-06-25",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "E. Amory",
"address": null,
"birth_date": null
},
"effective_date": "2025-06-25",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "B. Alsteens",
"address": null,
"birth_date": null
},
"effective_date": "2025-06-25",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "P. Legraive",
"address": null,
"birth_date": null
},
"effective_date": "2025-06-25",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel F\u00E9lix",
"address": null,
"birth_date": null
},
"effective_date": "2025-06-25",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e approuve la nomination de M. Emmanuel F\u00E9lix en qualit\u00E9 d\u0027administrateur."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}30-07-2025 3 directors appointed, 1 resigning
- Cristelle Noirhomme, Bestuurder
- Nathalie Houssein, Bestuurder
- Emmanuel Amory, Bestuurder
- Philippe Denoel, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philippe Denoel",
"address": null,
"birth_date": null
},
"evidence_quote": "Par ailleurs, M. Philippe Denoel est nomm\u00E9 comme \u2022 repr\u00E9sentant de la soci\u00E9t\u00E9 dans le cadre des fonctions d\u0027administrateur de cette derni\u00E8re dans les associations suivantes: Biowin ASBL (Avenue Georges Lema\u00EEtre 19-6041 Charleroi), WeIRI (Avenue Pasteur 6- 1300 Wavre | RPM: 0812.367.476) et le centre"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Cristelle Noirhomme",
"address": null,
"birth_date": null
},
"evidence_quote": "Mme Cristelle Noirhomme est nomm\u00E9e comme repr\u00E9sentante de la soci\u00E9t\u00E9 dans le cadre des fonctions d\u0027administrateur de cette derni\u00E8re dans les associations suivantes: UWE ASBL (Chemin du Stocquoy 3-1300 Wavre), Essenscia ASBL et Bio.be (Boulevard Auguste Reyers 80 - 1030 Bruxelles), Febeliec (Boulevar"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Nathalie Houssein",
"address": null,
"birth_date": null
},
"evidence_quote": "Mme Nathalie Houssein est nomm\u00E9e comme repr\u00E9sentante de la soci\u00E9t\u00E9 dans le cadre des fonctions d\u0027administrateur de cette derni\u00E8re dans l\u0027association suivante : L\u0027Alliance Centre BW ASBL (Chauss\u00E9e du Longchamp, 2-1300 Wavre)."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel Amory",
"address": null,
"birth_date": null
},
"evidence_quote": "M. Emmanuel Amory est nomm\u00E9 repr\u00E9sentant permanent de la soci\u00E9t\u00E9, au sens de l\u0027article 15 de la Loi du 27 octobre 2006 relative au contr\u00F4le des institutions de retraite professionnelle, pour le Fonds de Pension GSK BIOLOGICALS AAM (constitu\u00E9 et existant en vertu de la l\u00E9gislation belge, ayant son si"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}05-08-2024 8 reappointed
- I. Rapilly, Bestuurder
- A. Van Goethem, Bestuurder
- J. Louahed, Bestuurder
- R. Simard, Bestuurder
- E. Amory, Bestuurder
- B. Alsteens, Bestuurder
- P. Legraive, Bestuurder
- Gert Vanhees, Commissaris
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "I. Rapilly",
"address": null,
"birth_date": null
},
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "A. Van Goethem",
"address": null,
"birth_date": null
},
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "J. Louahed",
"address": null,
"birth_date": null
},
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "R. Simard",
"address": null,
"birth_date": null
},
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "E. Amory",
"address": null,
"birth_date": null
},
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "B. Alsteens",
"address": null,
"birth_date": null
},
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "P. Legraive",
"address": null,
"birth_date": null
},
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Gert Vanhees",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Deloitte R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale renomme \u00E0 l\u0027unanimit\u00E9 Deloitte R\u00E9viseurs d\u0027Entreprises, soci\u00E9t\u00E9 civile sous forme de SCRL ... repr\u00E9sent\u00E9e par Monsieur Gert Vanhees, pour un terme de 3 ans"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}03-07-2024 4 directors appointed
- Philippe Denoel, Bestuurder
- Cristelle Noirhomme, Bestuurder
- Nathalie Houssein, Bestuurder
- Emmanuel Amory, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philippe Denoel",
"address": null,
"birth_date": null
},
"evidence_quote": "Par ailleurs, M. Philippe Denoel est nomm\u00E9 comme \u2022 repr\u00E9sentant de la soci\u00E9t\u00E9 dans le cadre des fonctions d\u0027administrateur de cette derni\u00E8re dans les associations suivantes: Biowin ASBL (Avenue Georges Lema\u00EEtre 19-6041 Charleroi), WeIRI (Avenue Pasteur 6-1300 Wavre | RPM: 0812.367.476) et le centre "
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Cristelle Noirhomme",
"address": null,
"birth_date": null
},
"evidence_quote": "Mme Cristelle Noirhomme est nomm\u00E9e comme repr\u00E9sentante de la soci\u00E9t\u00E9 dans le cadre des fonctions d\u0027administrateur de cette derni\u00E8re dans les associations suivantes: UWE ASBL (Chemin du Stocquoy 3-1300 Wavre), Essenscia ASBL et Bio.be (Boulevard Auguste Reyers 80 - 1030 Bruxelles), Febeliec (Boulevar"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Nathalie Houssein",
"address": null,
"birth_date": null
},
"evidence_quote": "Mme Nathalie Houssein est nomm\u00E9e comme repr\u00E9sentante de la soci\u00E9t\u00E9 dans le cadre des fonctions d\u0027administrateur de cette derni\u00E8re dans l\u0027association suivante : L\u0027Alliance Centre BW ASBL (Chauss\u00E9e du Longchamp, 2-1300 Wavre)."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel Amory",
"address": null,
"birth_date": null
},
"evidence_quote": "M. Emmanuel Amory est nomm\u00E9 repr\u00E9sentant permanent de la soci\u00E9t\u00E9, au sens de l\u0027article 15 de la Loi du 27 octobre 2006 relative au contr\u00F4le des institutions de retraite professionnelle, pour le Fonds de Pension GSK BIOLOGICALS AAM (constitu\u00E9 et existant en vertu de la l\u00E9gislation belge, ayant son si"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}07-02-2024 Aglaé Van Goethem appointed as director
- Aglaé Van Goethem, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Agla\u00E9 Van Goethem",
"address": null,
"birth_date": null
},
"effective_date": "2023-09-18",
"evidence_quote": "Conform\u00E9ment \u00E0 l\u0027article 7 :88 \u00A71 du CSA et \u00E0 I\u0027Article 15 des statuts de la Soci\u00E9t\u00E9, le Conseil d\u00E9cide que le poste d\u0027administrateur vacant sera exerc\u00E9 par Mme Agla\u00E9 Van Goethem avec effet imm\u00E9diat."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}03-11-2023 Antoon LOOMANS resigns as director
- Antoon LOOMANS, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Antoon LOOMANS",
"address": null,
"birth_date": null
},
"effective_date": "2023-09-15",
"evidence_quote": "Par la pr\u00E9sente, je vous informe de ma d\u00E9mission du poste d\u0027administrateur de GlaxoSmith Kline Biologicals SA, avec effet ce vendredi 15 septembre 2023."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}23-08-2023 1 resigning, 7 reappointed
- Gert Vanhees, Commissaris
- I. Rapilly, Bestuurder
- J. Louahed, Bestuurder
- R. Simard, Bestuurder
- E. Amory, Bestuurder
- A. Loomans, Bestuurder
- B. Alsteens, Bestuurder
- P. Legraive, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "I. Rapilly",
"address": null,
"birth_date": null
},
"effective_date": "2023-06-28",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "J. Louahed",
"address": null,
"birth_date": null
},
"effective_date": "2023-06-28",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "R. Simard",
"address": null,
"birth_date": null
},
"effective_date": "2023-06-28",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "E. Amory",
"address": null,
"birth_date": null
},
"effective_date": "2023-06-28",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "A. Loomans",
"address": null,
"birth_date": null
},
"effective_date": "2023-06-28",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "B. Alsteens",
"address": null,
"birth_date": null
},
"effective_date": "2023-06-28",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "P. Legraive",
"address": null,
"birth_date": null
},
"effective_date": "2023-06-28",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Gert Vanhees",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Deloitte R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-06-28",
"evidence_quote": "Le mandat de commissaire de la soci\u00E9t\u00E9 civile sous forme de SCRL, Deloitte R\u00E9viseurs d\u0027Entreprises, ... repr\u00E9sent\u00E9e par Monsieur Gert Vanhees, expire \u00E0 l\u0027issue l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires qui se prononcera sur les comptes clos au 31 d\u00E9cembre 2023 et ne doit donc pas \u00EAtre renouvel"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}14-07-2023 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}24-03-2023 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}23-03-2023 Gabriel MILLAN resigns as director
- Gabriel MILLAN, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gabriel MILLAN",
"address": null,
"birth_date": null
},
"effective_date": "2023-03-01",
"evidence_quote": "Par la pr\u00E9sente, je vous informe de ma d\u00E9mission du poste d\u0027administrateur de GlaxoSmithKline Biologicals SA, avec effet au 1 mars 2023."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}14-02-2023 4 directors appointed
- Regis Simard, Bestuurder
- Benoît Alsteens, Bestuurder
- Pascal Legraive, Bestuurder
- Jamila Louahed, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Regis Simard",
"address": null,
"birth_date": null
},
"effective_date": "2023-01-10",
"evidence_quote": "En outre, l\u0027assembl\u00E9e d\u00E9cide d\u0027\u00E9lire en qualit\u00E9 d\u0027administrateur, \u00E0 compter de ce 10 janvier 2023, Messieurs Regis Simard, Beno\u00EEt Alsteens, Pascal Legraive et Mme Jamila Louahed."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Beno\u00EEt Alsteens",
"address": null,
"birth_date": null
},
"effective_date": "2023-01-10",
"evidence_quote": "En outre, l\u0027assembl\u00E9e d\u00E9cide d\u0027\u00E9lire en qualit\u00E9 d\u0027administrateur, \u00E0 compter de ce 10 janvier 2023, Messieurs Regis Simard, Beno\u00EEt Alsteens, Pascal Legraive et Mme Jamila Louahed."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Pascal Legraive",
"address": null,
"birth_date": null
},
"effective_date": "2023-01-10",
"evidence_quote": "En outre, l\u0027assembl\u00E9e d\u00E9cide d\u0027\u00E9lire en qualit\u00E9 d\u0027administrateur, \u00E0 compter de ce 10 janvier 2023, Messieurs Regis Simard, Beno\u00EEt Alsteens, Pascal Legraive et Mme Jamila Louahed."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jamila Louahed",
"address": null,
"birth_date": null
},
"effective_date": "2023-01-10",
"evidence_quote": "En outre, l\u0027assembl\u00E9e d\u00E9cide d\u0027\u00E9lire en qualit\u00E9 d\u0027administrateur, \u00E0 compter de ce 10 janvier 2023, Messieurs Regis Simard, Beno\u00EEt Alsteens, Pascal Legraive et Mme Jamila Louahed."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}01-08-2022 5 reappointed
- Roger Connor, Bestuurder
- Emmanuel Amory, Bestuurder
- Antoon Loomans, Bestuurder
- Gabriel Millan, Bestuurder
- Irène Rapilly, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Roger Connor",
"address": null,
"birth_date": null
},
"effective_date": "2022-06-22",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel Amory",
"address": null,
"birth_date": null
},
"effective_date": "2022-06-22",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Antoon Loomans",
"address": null,
"birth_date": null
},
"effective_date": "2022-06-22",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gabriel Millan",
"address": null,
"birth_date": null
},
"effective_date": "2022-06-22",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ir\u00E8ne Rapilly",
"address": null,
"birth_date": null
},
"effective_date": "2022-06-22",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}11-07-2022 Emmanuel Amory appointed as managing director
- Emmanuel Amory, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel Amory",
"address": null,
"birth_date": null
},
"effective_date": "2022-05-07",
"evidence_quote": "Le conseil d\u0027administration d\u00E9cide de d\u00E9l\u00E9guer la gestion journali\u00E8re \u00E0 M. Emmanuel Amory \u00E0 partir du 7 mai 2022 sur base de l\u0027article 20 b) des statuts. En cons\u00E9quence, M. Emmanuel Amory sera l\u0027administrateur d\u00E9l\u00E9gu\u00E9 de la soci\u00E9t\u00E9."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}11-07-2022 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}02-06-2022 Emmanuel Amory appointed as director
- Emmanuel Amory, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel Amory",
"address": null,
"birth_date": null
},
"effective_date": "2022-04-22",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer en qualit\u00E9 d\u0027administrateur, \u00E0 compter de ce jour, Monsieur Emmanuel Amory."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}23-02-2022 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}24-12-2021 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2021-12-16",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}30-07-2021 1 director appointed, 5 reappointed
- Irène Rapilly, Bestuurder
- Roger Connor, Bestuurder
- Patrick Florent, Bestuurder
- Antoon Loomans, Bestuurder
- Gabriel Millan, Bestuurder
- Gert Vanhees, Commissaris
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Roger Connor",
"address": null,
"birth_date": null
},
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Patrick Florent",
"address": null,
"birth_date": null
},
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Antoon Loomans",
"address": null,
"birth_date": null
},
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gabriel Millan",
"address": null,
"birth_date": null
},
"evidence_quote": "Sur proposition du conseil, se repr\u00E9sentent aux suffrages de l\u0027assembl\u00E9e, Messieurs Roger Connor, Patrick Florent, Gabriel Millan et Antoon Loomans. A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ir\u00E8ne Rapilly",
"address": null,
"birth_date": null
},
"effective_date": "2021-06-23",
"evidence_quote": "En outre, l\u0027assembl\u00E9e d\u00E9cide d\u0027\u00E9lire en qualit\u00E9 d\u0027administrateur, \u00E0 compter de ce jour, Madame Ir\u00E8ne Rapilly."
},
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Gert Vanhees",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Deloitte R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale renomme \u00E0 l\u0027unanimit\u00E9 Deloitte R\u00E9viseurs d\u0027Entreprises, soci\u00E9t\u00E9 civile sous forme de SCRL, Gateway Building, Luchthaven Nationaal 1J, 1930 Zaventem, repr\u00E9sent\u00E9e par Monsieur Gert Vanhees, pour un terme de 3 ans qui expirera \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale qui se prononcera sur"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}30-07-2021 Board meeting · Power of attorney
- Publication: 30/07/2021 · GlaxoSmithKline Biologicals SA
- Filing: 22/07/2021 · GlaxoSmithKline Biologicals SA
- Board meeting: 06/05/2021 · GlaxoSmithKline Biologicals SA
- Power of attorney: role: gestion journalière, start_date: 01/07/2021 · Patrick Florent
- Power of attorney: scope: opérations financières courantes (autres que salaires) jusqu'à 10.000.000 EUR, conditions: agissant conjointement deux à deux avec MM et Mmes Anna Maria Walkowiak-Kamińska, Beata Anna Szyszkowska, Astrid Luciane, Jacek Mironczuk, start_date: 01/07/2021 · Antigoni Alexandrou
- Power of attorney: scope: opérations financières courantes (autres que salaires) jusqu'à 10.000.000 EUR, conditions: agissant conjointement deux à deux, start_date: 01/07/2021 · Anna Maria Walkowiak-Kamińska
- Power of attorney: scope: opérations financières courantes (autres que salaires) jusqu'à 10.000.000 EUR, conditions: agissant conjointement deux à deux, start_date: 01/07/2021 · Beata Anna Szyszkowska
- Power of attorney: scope: opérations financières courantes (autres que salaires) jusqu'à 10.000.000 EUR, conditions: agissant conjointement deux à deux, start_date: 01/07/2021 · Astrid Luciane
- Power of attorney: scope: opérations financières courantes (autres que salaires) jusqu'à 10.000.000 EUR, conditions: agissant conjointement deux à deux, start_date: 01/07/2021 · Jacek Mironczuk
- Power of attorney: scope: opérations financières courantes (autres que salaires) jusqu'à 100.000.000 EUR, conditions: agissant conjointement deux à deux avec MM Daniel Beumier, Vincent Willemant et Mmes Carine Abras, Barbara Vinken et Déborah Puttemans, start_date: 01/07/2021 · Gabriel Millan
- Power of attorney: scope: opérations financières courantes (autres que salaires) jusqu'à 100.000.000 EUR, conditions: agissant conjointement deux à deux, start_date: 01/07/2021 · Daniel Beumier
- Power of attorney: scope: opérations financières courantes (autres que salaires) jusqu'à 100.000.000 EUR, conditions: agissant conjointement deux à deux, start_date: 01/07/2021 · Vincent Willemant
- Power of attorney: scope: opérations financières courantes (autres que salaires) jusqu'à 100.000.000 EUR, conditions: agissant conjointement deux à deux, start_date: 01/07/2021 · Carine Abras
- Power of attorney: scope: opérations financières courantes (autres que salaires) jusqu'à 100.000.000 EUR, conditions: agissant conjointement deux à deux, start_date: 01/07/2021 · Barbara Vinken
Technical details
{
"facts": [
{
"date": "2021-07-30",
"type": "publication",
"quote": "Belgisch Staatsblad - 30/07/2021",
"value": "30/07/2021",
"object": null,
"subject": "e1"
},
{
"date": "2021-07-22",
"type": "filing",
"quote": "TRIBUNAL DE L\u0027ENTREPRISE DU BRABANT WALLON 22 JUIL. 2021",
"value": "22/07/2021",
"object": null,
"subject": "e1"
},
{
"date": "2021-05-06",
"type": "board_meeting",
"quote": "Extrait du Proc\u00E8s-Verbal de la r\u00E9union du Conseil d\u0027Administration tenue le 6 mai 2021",
"value": "06/05/2021",
"object": null,
"subject": "e1"
},
{
"date": "2021-07-01",
"type": "power_of_attorney",
"quote": "la gestion journali\u00E8re est d\u00E9l\u00E9gu\u00E9e, en vertu de l\u0027article 20 b) des statuts, \u00E0 M. Patrick Florent.",
"value": {
"role": "gestion journali\u00E8re",
"start_date": "01/07/2021"
},
"object": "e1",
"subject": "e2"
},
{
"date": "2021-07-01",
"type": "power_of_attorney",
"quote": "Jusqu\u0027\u00E0 10.000.000 EUR: MM et Mmes Antigoni Alexandrou, Anna Maria Walkowiak-Kami\u0144ska, Beata Anna Szyszkowska, Astrid Luciane, Jacek Mironczuk agissant conjointement deux \u00E0 deux",
"value": {
"scope": "op\u00E9rations financi\u00E8res courantes (autres que salaires) jusqu\u0027\u00E0 10.000.000 EUR",
"conditions": "agissant conjointement deux \u00E0 deux avec MM et Mmes Anna Maria Walkowiak-Kami\u0144ska, Beata Anna Szyszkowska, Astrid Luciane, Jacek Mironczuk",
"start_date": "01/07/2021"
},
"object": "e1",
"subject": "e3"
},
{
"date": "2021-07-01",
"type": "power_of_attorney",
"quote": "MM et Mmes Antigoni Alexandrou, Anna Maria Walkowiak-Kami\u0144ska, Beata Anna Szyszkowska, Astrid Luciane, Jacek Mironczuk agissant conjointement deux \u00E0 deux",
"value": {
"scope": "op\u00E9rations financi\u00E8res courantes (autres que salaires) jusqu\u0027\u00E0 10.000.000 EUR",
"conditions": "agissant conjointement deux \u00E0 deux",
"start_date": "01/07/2021"
},
"object": "e1",
"subject": "e4"
},
{
"date": "2021-07-01",
"type": "power_of_attorney",
"quote": "MM et Mmes Antigoni Alexandrou, Anna Maria Walkowiak-Kami\u0144ska, Beata Anna Szyszkowska, Astrid Luciane, Jacek Mironczuk agissant conjointement deux \u00E0 deux",
"value": {
"scope": "op\u00E9rations financi\u00E8res courantes (autres que salaires) jusqu\u0027\u00E0 10.000.000 EUR",
"conditions": "agissant conjointement deux \u00E0 deux",
"start_date": "01/07/2021"
},
"object": "e1",
"subject": "e5"
},
{
"date": "2021-07-01",
"type": "power_of_attorney",
"quote": "MM et Mmes Antigoni Alexandrou, Anna Maria Walkowiak-Kami\u0144ska, Beata Anna Szyszkowska, Astrid Luciane, Jacek Mironczuk agissant conjointement deux \u00E0 deux",
"value": {
"scope": "op\u00E9rations financi\u00E8res courantes (autres que salaires) jusqu\u0027\u00E0 10.000.000 EUR",
"conditions": "agissant conjointement deux \u00E0 deux",
"start_date": "01/07/2021"
},
"object": "e1",
"subject": "e6"
},
{
"date": "2021-07-01",
"type": "power_of_attorney",
"quote": "MM et Mmes Antigoni Alexandrou, Anna Maria Walkowiak-Kami\u0144ska, Beata Anna Szyszkowska, Astrid Luciane, Jacek Mironczuk agissant conjointement deux \u00E0 deux",
"value": {
"scope": "op\u00E9rations financi\u00E8res courantes (autres que salaires) jusqu\u0027\u00E0 10.000.000 EUR",
"conditions": "agissant conjointement deux \u00E0 deux",
"start_date": "01/07/2021"
},
"object": "e1",
"subject": "e7"
},
{
"date": "2021-07-01",
"type": "power_of_attorney",
"quote": "Jusque \u00E0 100.000.000 EUR: MM.Gabriel Millan, Daniel Beumier, Vincent Willemant et Mmes, Carine Abras, Barbara Vinken et D\u00E9borah Puttemans agissant conjointement deux \u00E0 deux.",
"value": {
"scope": "op\u00E9rations financi\u00E8res courantes (autres que salaires) jusqu\u0027\u00E0 100.000.000 EUR",
"conditions": "agissant conjointement deux \u00E0 deux avec MM Daniel Beumier, Vincent Willemant et Mmes Carine Abras, Barbara Vinken et D\u00E9borah Puttemans",
"start_date": "01/07/2021"
},
"object": "e1",
"subject": "e8"
},
{
"date": "2021-07-01",
"type": "power_of_attorney",
"quote": "MM.Gabriel Millan, Daniel Beumier, Vincent Willemant et Mmes, Carine Abras, Barbara Vinken et D\u00E9borah Puttemans agissant conjointement deux \u00E0 deux.",
"value": {
"scope": "op\u00E9rations financi\u00E8res courantes (autres que salaires) jusqu\u0027\u00E0 100.000.000 EUR",
"conditions": "agissant conjointement deux \u00E0 deux",
"start_date": "01/07/2021"
},
"object": "e1",
"subject": "e9"
},
{
"date": "2021-07-01",
"type": "power_of_attorney",
"quote": "MM.Gabriel Millan, Daniel Beumier, Vincent Willemant et Mmes, Carine Abras, Barbara Vinken et D\u00E9borah Puttemans agissant conjointement deux \u00E0 deux.",
"value": {
"scope": "op\u00E9rations financi\u00E8res courantes (autres que salaires) jusqu\u0027\u00E0 100.000.000 EUR",
"conditions": "agissant conjointement deux \u00E0 deux",
"start_date": "01/07/2021"
},
"object": "e1",
"subject": "e10"
},
{
"date": "2021-07-01",
"type": "power_of_attorney",
"quote": "MM.Gabriel Millan, Daniel Beumier, Vincent Willemant et Mmes, Carine Abras, Barbara Vinken et D\u00E9borah Puttemans agissant conjointement deux \u00E0 deux.",
"value": {
"scope": "op\u00E9rations financi\u00E8res courantes (autres que salaires) jusqu\u0027\u00E0 100.000.000 EUR",
"conditions": "agissant conjointement deux \u00E0 deux",
"start_date": "01/07/2021"
},
"object": "e1",
"subject": "e11"
},
{
"date": "2021-07-01",
"type": "power_of_attorney",
"quote": "MM.Gabriel Millan, Daniel Beumier, Vincent Willemant et Mmes, Carine Abras, Barbara Vinken et D\u00E9borah Puttemans agissant conjointement deux \u00E0 deux.",
"value": {
"scope": "op\u00E9rations financi\u00E8res courantes (autres que salaires) jusqu\u0027\u00E0 100.000.000 EUR",
"conditions": "agissant conjointement deux \u00E0 deux",
"start_date": "01/07/2021"
},
"object": "e1",
"subject": "e12"
}
],
"act_meta": {
"outcome": "review",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 35945,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0440.872.918",
"kind": "company",
"name": "GlaxoSmithKline Biologicals SA",
"attrs": {
"seat": "89 rue de l\u0027Institut - 1330 Rixensart",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"short_name": "GSK Biologicals"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Patrick Florent",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Antigoni Alexandrou",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Anna Maria Walkowiak-Kami\u0144ska",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Beata Anna Szyszkowska",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Astrid Luciane",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Jacek Mironczuk",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Gabriel Millan",
"attrs": {}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Daniel Beumier",
"attrs": {}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "Vincent Willemant",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Carine Abras",
"attrs": {}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "Barbara Vinken",
"attrs": {}
},
{
"id": "e13",
"kbo": null,
"kind": "person",
"name": "D\u00E9borah Puttemans",
"attrs": {}
},
{
"id": "e14",
"kbo": null,
"kind": "person",
"name": "Carl Genard",
"attrs": {}
},
{
"id": "e15",
"kbo": null,
"kind": "person",
"name": "Frank Vandewal",
"attrs": {}
},
{
"id": "e16",
"kbo": null,
"kind": "person",
"name": "Fran\u00E7ois Pirard",
"attrs": {}
},
{
"id": "e17",
"kbo": null,
"kind": "person",
"name": "Val\u00E9rie Snauwaert",
"attrs": {}
},
{
"id": "e18",
"kbo": null,
"kind": "person",
"name": "Christelle Flamme",
"attrs": {}
},
{
"id": "e19",
"kbo": null,
"kind": "person",
"name": "Isabelle Janssens",
"attrs": {}
},
{
"id": "e20",
"kbo": null,
"kind": "person",
"name": "Michel Nevens",
"attrs": {}
},
{
"id": "e21",
"kbo": null,
"kind": "person",
"name": "Pascal Reyntjens",
"attrs": {}
},
{
"id": "e22",
"kbo": null,
"kind": "person",
"name": "Christophe Bertholet",
"attrs": {}
},
{
"id": "e23",
"kbo": null,
"kind": "person",
"name": "Joriathan Collin",
"attrs": {}
},
{
"id": "e24",
"kbo": null,
"kind": "person",
"name": "Nathalie Loicq",
"attrs": {}
},
{
"id": "e25",
"kbo": null,
"kind": "person",
"name": "Roger Connor",
"attrs": {}
},
{
"id": "e26",
"kbo": null,
"kind": "person",
"name": "Catherine Ghislain",
"attrs": {}
},
{
"id": "e27",
"kbo": null,
"kind": "person",
"name": "Loren Cooper",
"attrs": {}
},
{
"id": "e28",
"kbo": null,
"kind": "person",
"name": "Claude Copin",
"attrs": {}
},
{
"id": "e29",
"kbo": null,
"kind": "person",
"name": "Nathalie Houssein",
"attrs": {}
},
{
"id": "e30",
"kbo": null,
"kind": "person",
"name": "Antoon Loomans",
"attrs": {}
},
{
"id": "e31",
"kbo": null,
"kind": "person",
"name": "Andy Neefs",
"attrs": {}
},
{
"id": "e32",
"kbo": null,
"kind": "person",
"name": "Giovanni Novello",
"attrs": {}
},
{
"id": "e33",
"kbo": null,
"kind": "person",
"name": "Benoit Marchioni",
"attrs": {}
},
{
"id": "e34",
"kbo": null,
"kind": "person",
"name": "Isabelle Knott",
"attrs": {}
},
{
"id": "e35",
"kbo": null,
"kind": "person",
"name": "Christophe Pierret",
"attrs": {}
},
{
"id": "e36",
"kbo": null,
"kind": "person",
"name": "Koen Quanten",
"attrs": {}
},
{
"id": "e37",
"kbo": null,
"kind": "person",
"name": "Jonathan Jouret",
"attrs": {}
},
{
"id": "e38",
"kbo": null,
"kind": "person",
"name": "Mieke Verrue",
"attrs": {}
},
{
"id": "e39",
"kbo": null,
"kind": "person",
"name": "Philippe Denoel",
"attrs": {}
},
{
"id": "e40",
"kbo": null,
"kind": "person",
"name": "Cristelle Noirhomme",
"attrs": {}
},
{
"id": "e41",
"kbo": null,
"kind": "person",
"name": "Allisson Lightwine",
"attrs": {}
},
{
"id": "e42",
"kbo": null,
"kind": "person",
"name": "Elisabeth Van Damme",
"attrs": {}
},
{
"id": "e43",
"kbo": null,
"kind": "person",
"name": "Miek Waterschoot",
"attrs": {}
},
{
"id": "e44",
"kbo": null,
"kind": "person",
"name": "Isabelle Sneessens",
"attrs": {}
},
{
"id": "e45",
"kbo": null,
"kind": "person",
"name": "Ir\u00E8ne Rapilly",
"attrs": {}
},
{
"id": "e46",
"kbo": null,
"kind": "person",
"name": "G\u00E9raldine Selvais",
"attrs": {}
},
{
"id": "e47",
"kbo": null,
"kind": "person",
"name": "Caroline Strobbe",
"attrs": {}
},
{
"id": "e48",
"kbo": null,
"kind": "person",
"name": "Isabelle Leclercq",
"attrs": {}
},
{
"id": "e49",
"kbo": null,
"kind": "person",
"name": "C\u00E9line Kusters",
"attrs": {}
},
{
"id": "e50",
"kbo": null,
"kind": "person",
"name": "Matthias Van Holm",
"attrs": {}
},
{
"id": "e51",
"kbo": null,
"kind": "person",
"name": "Laurent Gevers",
"attrs": {}
},
{
"id": "e52",
"kbo": null,
"kind": "person",
"name": "David Legrain",
"attrs": {}
},
{
"id": "e53",
"kbo": null,
"kind": "person",
"name": "Patricia Pardon",
"attrs": {}
},
{
"id": "e54",
"kbo": null,
"kind": "person",
"name": "Sandrine Nuytten",
"attrs": {}
},
{
"id": "e55",
"kbo": null,
"kind": "person",
"name": "Ann Van Vijvere",
"attrs": {}
},
{
"id": "e56",
"kbo": null,
"kind": "person",
"name": "Laurent Nopere",
"attrs": {}
},
{
"id": "e57",
"kbo": null,
"kind": "person",
"name": "Alex Van Asch",
"attrs": {}
},
{
"id": "e58",
"kbo": null,
"kind": "person",
"name": "Hitesh Sahni",
"attrs": {}
},
{
"id": "e59",
"kbo": null,
"kind": "person",
"name": "Nicolas Chacun",
"attrs": {}
},
{
"id": "e60",
"kbo": null,
"kind": "person",
"name": "Maud Defer",
"attrs": {}
},
{
"id": "e61",
"kbo": null,
"kind": "person",
"name": "Tom Desmet",
"attrs": {}
},
{
"id": "e62",
"kbo": null,
"kind": "person",
"name": "Mohamed ElBahar",
"attrs": {}
},
{
"id": "e63",
"kbo": null,
"kind": "person",
"name": "Nelson Camejo",
"attrs": {}
},
{
"id": "e64",
"kbo": null,
"kind": "person",
"name": "Jens Schoemann",
"attrs": {}
},
{
"id": "e65",
"kbo": null,
"kind": "person",
"name": "An Vermeersch",
"attrs": {}
},
{
"id": "e66",
"kbo": null,
"kind": "person",
"name": "Thomas Breuer",
"attrs": {}
},
{
"id": "e67",
"kbo": null,
"kind": "person",
"name": "Bruno Quoidbach",
"attrs": {}
},
{
"id": "e68",
"kbo": null,
"kind": "person",
"name": "Christian Perez",
"attrs": {}
},
{
"id": "e69",
"kbo": null,
"kind": "person",
"name": "Dipal Patel",
"attrs": {}
},
{
"id": "e70",
"kbo": null,
"kind": "person",
"name": "Barbara Cygler",
"attrs": {}
},
{
"id": "e71",
"kbo": null,
"kind": "person",
"name": "Paul Kenny",
"attrs": {}
},
{
"id": "e72",
"kbo": null,
"kind": "person",
"name": "Thomas Stanson",
"attrs": {}
},
{
"id": "e73",
"kbo": null,
"kind": "person",
"name": "Jean Malthete",
"attrs": {}
},
{
"id": "e74",
"kbo": null,
"kind": "person",
"name": "Camille Chatagnon",
"attrs": {}
},
{
"id": "e75",
"kbo": null,
"kind": "person",
"name": "Jamila Louahed",
"attrs": {}
},
{
"id": "e76",
"kbo": null,
"kind": "person",
"name": "Tatjana Poplazarova",
"attrs": {}
},
{
"id": "e77",
"kbo": null,
"kind": "person",
"name": "Christine Marie Vanderlinden",
"attrs": {}
},
{
"id": "e78",
"kbo": null,
"kind": "person",
"name": "Sandrine Fontaine",
"attrs": {}
},
{
"id": "e79",
"kbo": null,
"kind": "person",
"name": "Priya Pavithran",
"attrs": {}
},
{
"id": "e80",
"kbo": null,
"kind": "person",
"name": "Santosh Mysore",
"attrs": {}
},
{
"id": "e81",
"kbo": null,
"kind": "person",
"name": "Stephen Griffiths",
"attrs": {}
},
{
"id": "e82",
"kbo": null,
"kind": "person",
"name": "Jim Janimak",
"attrs": {}
},
{
"id": "e83",
"kbo": null,
"kind": "person",
"name": "Ulrike Krause",
"attrs": {}
},
{
"id": "e84",
"kbo": null,
"kind": "person",
"name": "Luigi Bonfatti",
"attrs": {}
},
{
"id": "e85",
"kbo": null,
"kind": "person",
"name": "Laurence Baufays",
"attrs": {}
},
{
"id": "e86",
"kbo": null,
"kind": "person",
"name": "Jean Pernin",
"attrs": {}
},
{
"id": "e87",
"kbo": null,
"kind": "person",
"name": "Karl Walraverns",
"attrs": {}
},
{
"id": "e88",
"kbo": null,
"kind": "person",
"name": "Pascal Metters",
"attrs": {}
},
{
"id": "e89",
"kbo": null,
"kind": "person",
"name": "Uwe Nicolay",
"attrs": {}
},
{
"id": "e90",
"kbo": null,
"kind": "person",
"name": "C\u00E9cile Bamich",
"attrs": {}
},
{
"id": "e91",
"kbo": null,
"kind": "person",
"name": "Attila Geza Mihalyi",
"attrs": {}
},
{
"id": "e92",
"kbo": null,
"kind": "person",
"name": "Camelia Marcos",
"attrs": {}
},
{
"id": "e93",
"kbo": null,
"kind": "person",
"name": "Pierfrancesca Ceddia",
"attrs": {}
},
{
"id": "e94",
"kbo": null,
"kind": "person",
"name": "Piyali Mukherjee",
"attrs": {}
},
{
"id": "e95",
"kbo": null,
"kind": "person",
"name": "Bishoy Rizkalla",
"attrs": {}
},
{
"id": "e96",
"kbo": null,
"kind": "person",
"name": "Thierry De Block",
"attrs": {}
},
{
"id": "e97",
"kbo": null,
"kind": "person",
"name": "Koen De Heyder",
"attrs": {}
},
{
"id": "e98",
"kbo": null,
"kind": "person",
"name": "Matthew Sanders",
"attrs": {}
},
{
"id": "e99",
"kbo": null,
"kind": "person",
"name": "Sabine Leclercq",
"attrs": {}
},
{
"id": "e100",
"kbo": null,
"kind": "person",
"name": "Jean-Marc Wilkin",
"attrs": {}
},
{
"id": "e101",
"kbo": null,
"kind": "person",
"name": "Apostolos Mamakis",
"attrs": {}
},
{
"id": "e102",
"kbo": null,
"kind": "person",
"name": "Olivier Thiange",
"attrs": {}
},
{
"id": "e103",
"kbo": null,
"kind": "person",
"name": "Magali Berberof",
"attrs": {}
},
{
"id": "e104",
"kbo": null,
"kind": "person",
"name": "Michel Stoffel",
"attrs": {}
},
{
"id": "e105",
"kbo": null,
"kind": "person",
"name": "Denis Lassance",
"attrs": {}
},
{
"id": "e106",
"kbo": null,
"kind": "person",
"name": "Fr\u00E9d\u00E9ric Ren\u00E9 Sallmann",
"attrs": {}
},
{
"id": "e107",
"kbo": null,
"kind": "person",
"name": "Yannick Vanloubbeeck",
"attrs": {}
},
{
"id": "e108",
"kbo": null,
"kind": "person",
"name": "Dominique Descamps",
"attrs": {}
},
{
"id": "e109",
"kbo": null,
"kind": "person",
"name": "Marie-Th\u00E9r\u00E8se Martin",
"attrs": {}
},
{
"id": "e110",
"kbo": null,
"kind": "person",
"name": "Julian Bouchard",
"attrs": {}
},
{
"id": "e111",
"kbo": null,
"kind": "person",
"name": "Marguerite Deschamps",
"attrs": {}
},
{
"id": "e112",
"kbo": null,
"kind": "person",
"name": "Inma Lafuente",
"attrs": {}
},
{
"id": "e113",
"kbo": null,
"kind": "person",
"name": "Denis Beco",
"attrs": {}
},
{
"id": "e114",
"kbo": null,
"kind": "person",
"name": "Yannick Vernaeve-Schoen",
"attrs": {}
},
{
"id": "e115",
"kbo": null,
"kind": "person",
"name": "Emmanuel Felix",
"attrs": {}
},
{
"id": "e116",
"kbo": null,
"kind": "person",
"name": "Emmanuel Amory",
"attrs": {}
},
{
"id": "e117",
"kbo": null,
"kind": "person",
"name": "Scott McColm",
"attrs": {}
},
{
"id": "e118",
"kbo": null,
"kind": "person",
"name": "Jacqueline Berb\u00E9",
"attrs": {}
},
{
"id": "e119",
"kbo": null,
"kind": "person",
"name": "Carola Bleeker",
"attrs": {}
},
{
"id": "e120",
"kbo": null,
"kind": "person",
"name": "Philippe Ronse",
"attrs": {}
},
{
"id": "e121",
"kbo": null,
"kind": "person",
"name": "Beno\u00EEt Nannan",
"attrs": {}
},
{
"id": "e122",
"kbo": null,
"kind": "person",
"name": "Denis Lambrigts",
"attrs": {}
},
{
"id": "e123",
"kbo": null,
"kind": "person",
"name": "Marc P\u00E8re",
"attrs": {}
},
{
"id": "e124",
"kbo": null,
"kind": "person",
"name": "Benjamin-Nicolas Hulot",
"attrs": {}
},
{
"id": "e125",
"kbo": null,
"kind": "person",
"name": "Eric Sarlet",
"attrs": {}
},
{
"id": "e126",
"kbo": null,
"kind": "person",
"name": "Paul Nelis",
"attrs": {}
},
{
"id": "e127",
"kbo": null,
"kind": "person",
"name": "Laurence Colen",
"attrs": {}
},
{
"id": "e128",
"kbo": null,
"kind": "person",
"name": "Rubiati De Groot",
"attrs": {}
},
{
"id": "e129",
"kbo": null,
"kind": "person",
"name": "Fatima Ghaddih",
"attrs": {}
},
{
"id": "e130",
"kbo": null,
"kind": "person",
"name": "Lamia Azzi",
"attrs": {}
},
{
"id": "e131",
"kbo": null,
"kind": "person",
"name": "Pierre Leonard",
"attrs": {}
},
{
"id": "e132",
"kbo": null,
"kind": "person",
"name": "Johannes Carteus",
"attrs": {}
},
{
"id": "e133",
"kbo": null,
"kind": "person",
"name": "Stefania Marveggio",
"attrs": {}
},
{
"id": "e134",
"kbo": null,
"kind": "person",
"name": "Alain Herman",
"attrs": {}
},
{
"id": "e135",
"kbo": null,
"kind": "person",
"name": "Nicolas Magotteaux",
"attrs": {}
},
{
"id": "e136",
"kbo": null,
"kind": "person",
"name": "Alexandre De Neef",
"attrs": {}
},
{
"id": "e137",
"kbo": null,
"kind": "person",
"name": "Isabelle Collart",
"attrs": {}
},
{
"id": "e138",
"kbo": null,
"kind": "person",
"name": "Nadine Kok",
"attrs": {}
},
{
"id": "e139",
"kbo": null,
"kind": "person",
"name": "B\u00E9reng\u00E8re Facon",
"attrs": {}
},
{
"id": "e140",
"kbo": null,
"kind": "person",
"name": "Caterina Bartalucci",
"attrs": {}
},
{
"id": "e141",
"kbo": null,
"kind": "person",
"name": "Jean-Marie Legrand",
"attrs": {}
},
{
"id": "e142",
"kbo": null,
"kind": "person",
"name": "Herv\u00E9 de Hemptinne",
"attrs": {}
},
{
"id": "e143",
"kbo": null,
"kind": "person",
"name": "Marie Poncelet",
"attrs": {}
},
{
"id": "e144",
"kbo": null,
"kind": "person",
"name": "Charles Mees",
"attrs": {}
},
{
"id": "e145",
"kbo": null,
"kind": "person",
"name": "Bruno Doneux",
"attrs": {}
},
{
"id": "e146",
"kbo": null,
"kind": "person",
"name": "Thomas Jacques",
"attrs": {}
},
{
"id": "e147",
"kbo": null,
"kind": "person",
"name": "Olivier Steinmetz",
"attrs": {}
},
{
"id": "e148",
"kbo": null,
"kind": "person",
"name": "Bernard Lambert",
"attrs": {}
},
{
"id": "e149",
"kbo": null,
"kind": "person",
"name": "Fetmy Semlali",
"attrs": {}
},
{
"id": "e150",
"kbo": null,
"kind": "person",
"name": "Rennatte Georgescu",
"attrs": {}
},
{
"id": "e151",
"kbo": null,
"kind": "person",
"name": "Gisela Payeras",
"attrs": {}
}
]
}10-02-2021 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}13-10-2020 1 director appointed, 1 resigning
- Gert Vanhees, Commissaris
- Eric Nys, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Eric Nys",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Deloitte R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2020-01-01",
"evidence_quote": "Le repr\u00E9sentant permanent du commissaire, la soci\u00E9t\u00E9 coop\u00E9rative \u00E0 responsabilit\u00E9 limit\u00E9e Deloitte R\u00E9viseurs d\u0027Entreprises, dont le si\u00E8ge se situe Gateway building, Luchthaven Brussel Nationaal 1 J, B-1930 Zaventem, est dor\u00E9navant Gert Vanhees en lieu de place de Eric Nys."
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Gert Vanhees",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Deloitte R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2020-01-01",
"evidence_quote": "Le repr\u00E9sentant permanent du commissaire, la soci\u00E9t\u00E9 coop\u00E9rative \u00E0 responsabilit\u00E9 limit\u00E9e Deloitte R\u00E9viseurs d\u0027Entreprises, dont le si\u00E8ge se situe Gateway building, Luchthaven Brussel Nationaal 1 J, B-1930 Zaventem, est dor\u00E9navant Gert Vanhees en lieu de place de Eric Nys."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}17-08-2020 1 director appointed, 6 reappointed
- Gabriel Millan, Bestuurder
- Roger Connor, Bestuurder
- Patrick Florent, Bestuurder
- Emmanuel Hanon, Bestuurder
- Gunther Koch, Bestuurder
- Antoon Loomans, Bestuurder
- Eric Nys, Commissaris
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Roger Connor",
"address": null,
"birth_date": null
},
"effective_date": "2020-06-24",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Patrick Florent",
"address": null,
"birth_date": null
},
"effective_date": "2020-06-24",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel Hanon",
"address": null,
"birth_date": null
},
"effective_date": "2020-06-24",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gunther Koch",
"address": null,
"birth_date": null
},
"effective_date": "2020-06-24",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Antoon Loomans",
"address": null,
"birth_date": null
},
"effective_date": "2020-06-24",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gabriel Millan",
"address": null,
"birth_date": null
},
"effective_date": "2020-06-24",
"evidence_quote": "En outre, l\u0027assembl\u00E9e d\u00E9cide d\u0027\u00E9lire en qualit\u00E9 d\u0027administrateur, \u00E0 compter de ce jour, Monsieur Gabriel Millan."
},
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Eric Nys",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Deloitte R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Le mandat de commissaire de la soci\u00E9t\u00E9 civile sous forme de SCRL, Deloitte R\u00E9viseurs d\u0027Entreprises, ... repr\u00E9sent\u00E9e par Monsieur Eric Nys, expirera \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale qui se prononcera sur les comptes clos au 31 d\u00E9cembre 2020 et ne doit donc pas \u00EAtre renouvel\u00E9."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}17-07-2020 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}26-06-2020 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}14-02-2020 Capital increase of €3,703,566,240 to €13,479,632,620.82
- €9.776.066.380,82 → €13.479.632.620,82
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 3703566240.0,
"currency": "EUR",
"after_eur": 13479632620.82,
"delta_eur": 3703566240.0,
"before_eur": 9776066380.82,
"amount_type": "kapitaal_effectief",
"effective_date": "2020-01-30",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital social pour le porter de neuf milliards sept cent septante-six millions soixante-six mille trois cent quatre-vingts euros quatre-vingt-deux cents (9.776.066.380,82 EUR) \u00E0 treize milliards quatre cent septante-neuf millions six cent trente-deux mille six cent vingt euros quatre-vingt-deux cents (13.479.632.620,82 EUR), par incorporation d\u2019une somme de trois milliards sept cent trois millions cinq cent soixante-six mille deux cent quarante euros (3.703.566.240,00 EUR) \u00E0 pr\u00E9lever sur les r\u00E9serves disponibles de la soci\u00E9t\u00E9 telles qu\u2019elles figurent sur les comptes annuels cl\u00F4tur\u00E9s le 31 d\u00E9cembre 2018",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}09-08-2019 2 directors appointed, 1 resigning, 4 reappointed
- Roger Connor, Bestuurder
- Emmanuel Hanon, Bestuurder
- Eric Nys, Commissaris
- Patrick Florent, Bestuurder
- Gunther Koch, Bestuurder
- Antoon Loomans, Bestuurder
- Jay Green, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Patrick Florent",
"address": null,
"birth_date": null
},
"effective_date": "2019-06-26",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gunther Koch",
"address": null,
"birth_date": null
},
"effective_date": "2019-06-26",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Antoon Loomans",
"address": null,
"birth_date": null
},
"effective_date": "2019-06-26",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jay Green",
"address": null,
"birth_date": null
},
"effective_date": "2019-06-26",
"evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e renouvelle les mandats de tous les administrateurs susmentionn\u00E9s."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Roger Connor",
"address": null,
"birth_date": null
},
"effective_date": "2019-06-26",
"evidence_quote": "En outre, l\u0027assembl\u00E9e d\u00E9cide d\u0027\u00E9lire en qualit\u00E9 d\u0027administrateur, \u00E0 compter de ce jour, Messieurs Roger Connor et Emmanuel Hanon."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel Hanon",
"address": null,
"birth_date": null
},
"effective_date": "2019-06-26",
"evidence_quote": "En outre, l\u0027assembl\u00E9e d\u00E9cide d\u0027\u00E9lire en qualit\u00E9 d\u0027administrateur, \u00E0 compter de ce jour, Messieurs Roger Connor et Emmanuel Hanon."
},
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Eric Nys",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0440872918",
"name": "Deloitte R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Le mandat de commissaire de la soci\u00E9t\u00E9 civile sous forme de SCRL, Deloitte R\u00E9viseurs d\u0027Entreprises, ... repr\u00E9sent\u00E9e par Monsieur Eric Nys, expirera \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale qui se prononcera sur les comptes clos au 31.12.2020 et ne doit donc pas \u00EAtre renouvel\u00E9."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0440.872.918",
"name_full": "GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS OU SMITHKLINE BEECHAM BIOLOGICALS",
"legal_form": "SA"
}
}| Legal nameFR | GlaxoSmithKline Biologicals |
| AbbreviationFR | GSK Biologicals - SmithKline Beecham Biologicals |